24524-90-1

Basic information

• Product Name: 1,2,3,4-tetrahydro-2-methyl-4-phenylisoquinolin-8-amine maleate
• Synonyms: 1,2,3,4-tetrahydro-2-methyl-4-phenylisoquinolin-8-amine maleate;1,2,3,4-Tetrahydro-2-methyl-4-phenyl-8-isoquinolinamine/(Z)-2-butenedioic acid,(1:x)
• CAS NO: 24524-90-1
• Molecular Formula: C₄H₄O₄*C₁₆H₁₈N₂
• Molecular Weight: 354.39968
• EINECS: 246-297-2
• Mol File: 24524-90-1.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 378.4°Cat760mmHg
• Flash Point: 164°C
• Appearance: /
• Density: g/cm³
• Vapor Pressure: 6.28E-06mmHg at 25°C
• CAS DataBase Reference: 1,2,3,4-tetrahydro-2-methyl-4-phenylisoquinolin-8-amine maleate(CAS DataBase Reference)
• NIST Chemistry Reference: 1,2,3,4-tetrahydro-2-methyl-4-phenylisoquinolin-8-amine maleate(24524-90-1)
• EPA Substance Registry System: 1,2,3,4-tetrahydro-2-methyl-4-phenylisoquinolin-8-amine maleate(24524-90-1)

Safety Data

• Hazardous Substances Data: 24524-90-1(Hazardous Substances Data)

Usage

Description

1,2,3,4-Tetrahydro-2-methyl-4-phenylisoquinolin-8-amine maleate, also known as talsaclidine, is a chemical compound with potential therapeutic benefits for the treatment of neurodegenerative disorders such as Parkinson's disease. It functions as a selective M1 muscarinic receptor agonist, which aids in enhancing cognitive function and motor control in affected patients. Talsaclidine has been the subject of extensive research and clinical trials, demonstrating promise as a treatment option. However, further studies are necessary to fully comprehend its mechanisms of action and potential side effects. As a result, talsaclidine remains an active area of research and development in the field of neurodegenerative disorder treatments.

Uses

Used in Pharmaceutical Industry:
1,2,3,4-Tetrahydro-2-methyl-4-phenylisoquinolin-8-amine maleate is used as a therapeutic agent for the treatment of neurodegenerative disorders, specifically targeting Parkinson's disease. Its role as a selective M1 muscarinic receptor agonist helps improve cognitive function and motor control in patients, offering a potential treatment option for those suffering from these debilitating conditions.
Used in Research and Development:
1,2,3,4-Tetrahydro-2-methyl-4-phenylisoquinolin-8-amine maleate is utilized in ongoing research and development efforts to better understand its mechanisms of action and potential side effects. This knowledge is crucial for optimizing its therapeutic potential and ensuring its safety and efficacy as a treatment for neurodegenerative disorders.

InChI:InChI=1/C16H18N2.C4H4O4/c1-18-10-14(12-6-3-2-4-7-12)13-8-5-9-16(17)15(13)11-18;5-3(6)1-2-4(7)8/h2-9,14H,10-11,17H2,1H3;1-2H,(H,5,6)(H,7,8)/b;2-1-